The Directorate General of Foreign Trade vide its notification dated 4th April 2022 has extended the date for implementation of Track and Trace system for export of drug formulations with respect to maintaining the Parent-Child relationship in packaging levels and its uploading on Central Portal to 31.3.2023 for both SSI (small scale industries) and non SSI manufactured drugs.
Para 2.90A states that export of drugs manufactured by SSI and non-SSI units and having manufacturing date on or before 01.04.2022 are exempted from maintenance of data in the Parent-Child relationship for three levels of packaging and its uploading on Central Portal (http://dava.gov.in).
All drugs manufactured by SSI or non SSI units and having manufacturing date after 01.04.2022 can be exported only if both tertiary and secondary packaging carry barcoding as applicable and the relevant data as prescribed by DGFT is uploaded on the Central Portal.
